Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.32 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.32 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.32 |
| ▸ | PTPRF | P10586 | 1/20 | 0.30 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.30 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.30 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | FYN | P06241 | 1/20 | 0.30 |
| ▸ | MAPK3 | P27361 | 1/20 | 0.30 |
| ▸ | AHR | P35869 | 1/20 | 0.30 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.30 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25645386 | 0.93 | PLA2G2A (0.34) | ALOX5PLA2G2APLA2G4APTPRFPTPN2 | |
| SCHEMBL25645407 | 0.89 | ALOX5 (0.35) | ALOX5AHR | |
| SCHEMBL25645376 | 0.87 | ALOX5 (0.34) | ALOX5PLA2G2APLA2G4AAHRABCG2 | |
| SCHEMBL25731519 | 0.86 | CYP1A1 (0.38) | CYP1A1CYP1A2FYNMAPK3AHR | |
| SCHEMBL25640500 | 0.86 | ABCG2 (0.38) | CYP1A1CYP1A2FYNMAPK3AHR | |
| SCHEMBL25640592 | 0.86 | LMNA (0.31) | PTPRFPTPN2PTPN1 | |
| SCHEMBL25731154 | 0.86 | CYP1A1 (0.34) | CYP1A1CYP1A2FYNMAPK3AHR | |
| SCHEMBL25731151 | 0.86 | CYP1A1 (0.34) | CYP1A1CYP1A2FYNMAPK3AHR | |
| SCHEMBL25640656 | 0.86 | CYP1A1 (0.34) | PLA2G2APLA2G4ACYP1A1CYP1A2FYN | |
| SCHEMBL23598100 | 0.85 | ALOX5 (0.34) | ALOX5PLA2G2APLA2G4AAHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210119142-A1 | ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. (KR) | 2021-04-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210119142-A1 | ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | ICOSLG, ELAVL1, OR10J3 | ALOX5 568/4885PLA2G2A 3360/4885PLA2G4A 3354/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.